Shopping Cart 0
Cart Subtotal
AED 0

Juvenile Diabetes Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type 1 diabetes. The organization conducts clinical trials for curing, preventing and treating for type 1 diabetes and its complications; and researching new drugs for patients to manage diabetes. It also performs clinical trials and tolerance assay studies in transplantation, autoimmune diseases, and allergy and asthma. JDRF provides diabetes clinical trials to laboratories, educational institutions, and pharmaceutical and medical research companies. The organization has operations in Australia, Canada, Denmark, Israel, Netherlands and the UK. It partners with pharmaceuticals, healthcare and automobile companies to eradicate type 1 diabetes. JDRF is headquartered in New York, the US.

Juvenile Diabetes Research Foundation-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Juvenile Diabetes Research Foundation, Medical Devices Deals, 2012 to YTD 2018 10

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

T1D Innovations Raises USD 5 Million In Venture Financing 13

Partnerships 14

Juvenile Diabetes and Gubra Enter into Partnership Agreement 14

Biocon Enters into Agreement with Juvenile Diabetes Research Foundation 15

vTv Therapeutics Enters into Agreement with Juvenile Diabetes Research Foundation 16

JDRF Enters into Agreement with Pacific Diabetes Technologies 17

Diamyd Medical Enter into Partnership with Janssen R&D, JDRF and UAB 18

MannKind Partners with JDRF 19

Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 20

Regimmune Enters into Research Agreement with JDRF and Pfizer 22

European Foundation for the Study of Diabetes, JDRF and Eli Lilly Extends Research Agreement 23

Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 24

Juvenile Diabetes Research Partners with Xeris Pharma and LATITUDE Pharma 25

Novo Nordisk Enters Into R&D Agreement With Juvenile Diabetes Research Foundation For Type 1 Diabetes 26

KalVista Pharma Enters Into Research Agreement With JDRF 27

Equity Offering 28

Bigfoot Biomedical Raises Funds in Equity Financing 28

AnTolRx to Raise USD4 Million in Private Placement of Shares 29

Sernova to Raise USD2.5 Million in Private Placement of Shares 30

Juvenile Diabetes Research Foundation-Key Competitors 31

Juvenile Diabetes Research Foundation-Key Employees 32

Juvenile Diabetes Research Foundation-Locations And Subsidiaries 34

Head Office 34

Recent Developments 35

Government and Public Interest 35

May 03, 2018: JDRF Awards International Diabetes Center Grant to Investigate the Use of Intranasal Insulin Delivery 35

Apr 10, 2018: JDRF, ADA and Helmsley Charitable Trust Issue Request for Proposals to Research Consistency and Potency of Insulin Purchased in U.S. Pharmacies 36

Mar 08, 2018: Unique inflammation patterns emerging in patients with type 1 diabetes 37

Feb 22, 2018: Frequency Therapeutics Awarded Grant from JDRF to Generate Glucose-Responsive Insulin-Secreting Cells for Type 1 Diabetes Treatment Using a Small Molecule Approach 38

Jan 04, 2018: Gene therapy restores normal blood glucose levels in mice with type 1 diabetes 39

Aug 31, 2017: Role of gut bacteria in averting Type 1 diabetes 40

Aug 01, 2017: Case Western Reserve University: Missing Signals Leads to Diabetic Nerve Injury 42

Mar 20, 2017: New Research Identifies Novel Target for Controlling Immune Response to Implanted Materials 43

Feb 27, 2017: City of Hope Researchers Discover New Potential Cause of Type 1 Diabetes 44

Feb 07, 2017: JDRF & Lilly Canada fund UBC research that could allow people with type 1 diabetes to produce their own insulin 46

Jan 12, 2017: JDRF Encouraged by Medicare Decision to Take First Step Toward Coverage of Continuous Glucose Monitors for People with Type 1 Diabetes 47

Product News 48

Jul 09, 2018: Human clinical trial reveals verapamil as an effective Type 1 diabetes therapy 48

Other Significant Developments 50

May 01, 2018: JDRF participates in new Research Project Hypo-RESOLVE to investigate Hypoglycaemia and its Impact in Diabetes 50

Feb 15, 2018: JDRF and The Mary Tyler Moore & S. Robert Levine, MD Charitable Foundation Launch Research Moonshot to Restore Vision in People with Diabetes-Related Eye Disease 51

Jan 09, 2018: JDRF Research Accomplishments Lead the Way to Prevent Future Type 1 Diabetes Diagnoses 53

Dec 01, 2017: JDRF Launches Health Insurance Guide to Help People with Type 1 Diabetes Navigate Common Insurance Challenges 55

Appendix 56

Methodology 56

About GlobalData 56

Contact Us 56

Disclaimer 56


List Of Figure

List of Figures

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Juvenile Diabetes Research Foundation, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Key Facts 2

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Juvenile Diabetes Research Foundation, Deals By Therapy Area, 2012 to YTD 2018 9

Juvenile Diabetes Research Foundation, Medical Devices Deals, 2012 to YTD 2018 10

Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

T1D Innovations Raises USD 5 Million In Venture Financing 13

Juvenile Diabetes and Gubra Enter into Partnership Agreement 14

Biocon Enters into Agreement with Juvenile Diabetes Research Foundation 15

vTv Therapeutics Enters into Agreement with Juvenile Diabetes Research Foundation 16

JDRF Enters into Agreement with Pacific Diabetes Technologies 17

Diamyd Medical Enter into Partnership with Janssen R&D, JDRF and UAB 18

MannKind Partners with JDRF 19

Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 20

Regimmune Enters into Research Agreement with JDRF and Pfizer 22

European Foundation for the Study of Diabetes, JDRF and Eli Lilly Extends Research Agreement 23

Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 24

Juvenile Diabetes Research Partners with Xeris Pharma and LATITUDE Pharma 25

Novo Nordisk Enters Into R&D Agreement With Juvenile Diabetes Research Foundation For Type 1 Diabetes 26

KalVista Pharma Enters Into Research Agreement With JDRF 27

Bigfoot Biomedical Raises Funds in Equity Financing 28

AnTolRx to Raise USD4 Million in Private Placement of Shares 29

Sernova to Raise USD2.5 Million in Private Placement of Shares 30

Juvenile Diabetes Research Foundation, Key Competitors 31

Juvenile Diabetes Research Foundation, Key Employees 32

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Juvenile Diabetes Research Foundation, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.